Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Accumulation U.S. costs saved through generic pharmaceuticals 2004-2013

Accumulated cost savings through generics in the United States in the period 2004-2013 (in billion U.S. dollars)

by Statista Research Department, last edited Oct 30, 2014
Accumulation U.S. costs saved through generic pharmaceuticals 2004-2013 This statistic displays the accumulated cost savings in the United States associated with using generic pharmaceuticals within the period 2004-2013. During this period, 888 billion U.S. dollars in accumulated cost savings were through older generic products. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals in the United States in total.
Show more

Accumulated cost savings through generics in the United States in the period 2004-2013 (in billion U.S. dollars)

Accmulated cost savings in billion U.S. dollars
--
--
Accmulated cost savings in billion U.S. dollars
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Oct 30, 2014
This statistic displays the accumulated cost savings in the United States associated with using generic pharmaceuticals within the period 2004-2013. During this period, 888 billion U.S. dollars in accumulated cost savings were through older generic products. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals in the United States in total.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Generics and biosimilars"
  • Global overview
The most important statistics
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.